FFH Network × National MS Society × [Your Institution]
🧠 Prepared Patient Series · Course #11

Become a Certified Prepared Patient
for Multiple Sclerosis

A guided learning path that turns you (and your care partner) into the most informed, confident, and effective members of your own care team. Modern high-efficacy DMTs. Relapse vs pseudo-relapse. The lifestyle Force Field — heat, exercise, sleep, vitamin D, smoking cessation, mental health. Honest framing on cost and access. Comorbidity awareness. ADA accommodations and long-arc planning. Fewer ED visits. A longer, fuller life — and the skills to help others do the same.

3HEALTH-LITERACY LAYERS
10EVIDENCE-BASED COMPETENCIES
3IDENTITIES YOU EARN
1HEALTH PASSPORT (FRIDGE-READY)
1
Learn It
2
Live It
3
Share It
Force Field strength: 0% (0/10 competencies)
Demo Banner client preview — synthetic data for walk-through. Use these buttons to populate or reset the demo experience.
Customizable Welcome from [Your Institution Name]. Need help with this course? Call our MS Care navigator [Navigator name, RN / SW — (555) 123-4567], M–F 8a–5p, or the National MS Society MS Navigator 1-800-344-4867. You can also message us through the [MyChart patient portal].
🛡 Force Field Fact Sheet New here? Start with the one-page Force Field Fact Sheet — 16 squares of essential Multiple Sclerosis knowledge, plain-language, printable, free. Then come back for your full Certified Prepared Patient course. Open Fact Sheet →
🏅Your Path to Certification

Earn your way up three evidence-based tiers. Each builds on the last. Finish all three and receive your Certified Prepared Patient · Multiple Sclerosis badge and printable certificate, recognized across the FFH Network.

Tier 1

Aware · Identity: Self-Advocate

You know your body and your disease. Layer 1 — Condition Literacy.

  • Complete Modules 1–4 (Condition Literacy)
  • Pass the "What MS Is" quiz (≥80%)
  • Identify your MS subtype (RRMS, SPMS, PPMS) and your latest MRI lesion burden
  • Build your weekly lifestyle tracker (heat, exercise, sleep, vitamin D) + relapse/symptom diary with the FFH "Notice and Name" framework
2 of 4 done50%
Tier 2

Active · Identity: Care Team Member

You partner with your team and navigate the system. Layer 2 — Care & System Literacy.

  • Complete Modules 5–7 (Make Every Visit Count · When to Call vs ED · Comorbidity Awareness)
  • Demonstrate teach-back on your DMT plan and your relapse vs pseudo-relapse decision rule
  • Complete one "great visit" prep + debrief
  • Build your When-to-Call plan + Care Team card
  • Successfully resolve one DMT prior auth, copay-help application, or MS nurse-navigator engagement
0 of 5 done0%
Tier 3 · Certified

Certified Prepared Patient · Identity: Ambassador

You teach, mentor, fight stigma, and shape research & policy. Layer 3 — Advocacy & Ambassadorship.

  • Complete Modules 8–10 (Family & Care Team · Talk to Kids/Partner/Employer + Mentor · Mastery & Graduation)
  • Mentor 1 newly-diagnosed person OR present at a support group / school / faith community
  • Sign the Prepared Patient Pledge
  • Complete advance care planning (POA, proxy, advance directive, POLST/MOLST, will)
  • Submit one advocacy action (story, feedback letter, trial review, policy comment)
0 of 5 done0%
📋Master Pre / Post Assessment 7 Likert dimensions · open to take or review

Where You Stand — Confidence Before & After

Seven dimensions of being a Prepared Patient. Answer once at the start of your journey and again at the end. Your goal is to see real growth across understanding, self-management, communication, and optimal utilization — knowing when to call your team, when to use Day Hospital, and when to go to the ER. Your answers stay on this device unless you choose to share with your clinician.

📈 Your Pre→Post Growth

Saved on this device · No backend yet · PHIT integration after Banner demo
📞Know Who to Call — Before the ER

MS care runs on a long arc — most days are routine, some days bring relapses or symptom flares, and rare moments are true emergencies. Knowing the right number to call — your MS team, the National MS Society MS Navigator, or 911 — saves time, dignity, and unnecessary ED visits. Save these numbers in your phone today. The numbers below are placeholders — your institution will fill in the right ones for you.

🚨 New neurological symptom >24 hr — could be a relapse

New numbness, weakness, painful vision loss in one eye (optic neuritis), severe imbalance, double vision, or new bladder/bowel change lasting more than 24 hours and not explained by fever or exertion — call your [MS Clinic On-Call: (555) 222-9000] within 24–48 hours. UTI is the #1 trigger of pseudo-relapse — always ruled out first. If sudden one-sided weakness, face droop, slurred speech, or sudden severe headache — that's BE-FAST positive — 911 (people with MS can also have strokes).

🧭 Worsening fatigue, mood, bladder, or cognition — call before the ED

For worsening fatigue out of proportion, depression / anxiety, new bladder symptoms, or cognitive change interfering with life, call your [MS Nurse Navigator: (555) 123-4567]. Most are addressable in clinic with rehab, behavioral health, urology, or symptom-management agents — the ED is rarely the right setting.

💬 Routine questions, refills, scheduling, peer support

Use [MyChart portal] first — most messages answered within 1 business day. For DMT refills or copay help, call [MS Specialty Pharmacy: (555) 222-9050]. For peer support, mentor matching, and local resources, call the National MS Society MS Navigator 1-800-344-4867 — free, real humans, weekdays.

🚑 Call 911 right away for any of these

Sudden one-sided weakness · face droop · slurred speech · sudden severe headache · sudden vision change · sudden balance loss · trouble understanding speech (BE-FAST positive — could be stroke). New or first-time seizure, status epilepticus (seizure >5 min), severe injury, suspected aspiration, breathing trouble — 911. Note the last known well or last seen time.

📚Condition Literacy & the 10 Prepared Patient Competencies

A Prepared Patient builds three kinds of health literacy — and grows into three identities. Each competency works through the FFH three pillars: Learn It · Live It · Share It.

🛡️

Advocate for Self

You speak up for your own care, plan, pain, and goals.

🤝

Care Team Member

You partner with your team — not above, not below.

📣

Ambassador

You teach, mentor, and shape research, policy & access.

1

🧬 Condition Literacy Learn It · Tier 1 Aware

"I know my body and my disease." The foundation. Without this, nothing else holds.

Identity earned: Self-AdvocateCompetencies 1–4
1 🧠

What MS Is

Autoimmune attack on myelin in brain, spinal cord, and optic nerves. RRMS (most common at diagnosis), SPMS, PPMS. Lesions on MRI. Modern early high-efficacy DMT has changed the long-arc trajectory.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
2 🩸

Know My Numbers & Risk Factors

Annualized relapse rate, MRI T2 + gadolinium-enhancing lesions, EDSS, vitamin D (40–60 ng/mL), BMI, smoking status. EBV near-prerequisite. Vascular comorbidities accelerate MS disability.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
3 🥗

Lifestyle Force Field — Heat, Movement, Sleep, Mood

Heat management (cooling vest, AC), exercise IS recommended (myth long debunked), 7–9 hr sleep, smoking cessation, Mediterranean eating, vitamin D, mental health, social connection. Stack 3–4 and you bend the long arc.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
4 💊

Modern High-Efficacy DMTs

Three tiers: high-efficacy (ocrelizumab, ofatumumab, natalizumab, alemtuzumab, cladribine), oral S1P (fingolimod, ozanimod, siponimod, ponesimod), platform (interferons, glatiramer, fumarates, teriflunomide). Recent evidence: start high-efficacy early.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
2

🤝 Care & System Literacy Live It · Tier 2 Active

"I'm part of the team. I navigate the system." Where most preventable ER visits, readmissions, and frustration happen — and where this course pays off the most. Optimal utilization lives here.

Identity earned: Care-Team MemberCompetencies 5–7
5 📊

Make Every Visit Count — SHARE Approach + Teach-Back

AHRQ SHARE Approach (Seek, Help, Assess, Reach, Evaluate). Teach-back at every visit. 3-question max written priority list. Numbers card + med list + second pair of ears. Visits run short — preparation multiplies value.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
6 🚨

When to Call vs Go to ED — Relapse, Pseudo-Relapse, Optic Neuritis

True relapse → call MS team within 24–48 hr. Pseudo-relapse (heat/UTI/fatigue) → cool down + treat trigger. Optic neuritis → same-day eval. Severe weakness/breathing → ED. BE-FAST positive → 911 (people with MS can also have strokes).

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
7 🌐

Comorbidity Awareness — Vascular, Mood, Cognition, OAB, OSA, Bone Health

MS-specific Module 7. Vascular comorbidities (HTN, T2D, OSA) accelerate MS disability — cross-references the upstream vascular cluster. Mood >50% lifetime. Cognitive ~40–65%. OAB + UTI #1 pseudo-relapse trigger. Bone health w/ steroid pulses.

Learn ItLive It
My confidence (1–5)
Pre: — · Post: —
3

📣 Advocacy & Ambassadorship Share It · Tier 3 Certified

"I speak up. I lift others. I shape the future." This is what turns a Prepared Patient into a force multiplier for the whole community.

Identity earned: AmbassadorCompetencies 8–10
8 🤝

Family, Caregiver, and the Care Team

The care partner is the second patient — caregiver burden + respite are real medicine. The MS team: MS-specialist neurology + MS nurse navigator + PT/OT + urology + psychiatry + ophthalmology + pharmacist + NMSS peer mentor. The "invisible" symptoms (fatigue, cognition, mood) need explicit conversation.

Learn It
My confidence (1–5)
Pre: — · Post: —
9 🎤

Sharing — Talk to Kids, Partner, Employer; Mentor

Kids: plain language + reassurance. Partners: long-arc planning across decades. Employers: ADA accommodations (cooler workspace, flex hours, fatigue-aware scheduling). FMLA / SSDI. Peer mentor — change a newly-diagnosed person's prognosis. FFH "Notice and Name" Ambassador framework — observation, never diagnosis.

My confidence (1–5)
Pre: — · Post: —
10 🏆

Mastery & Graduation — Long-Term Self-Advocacy + Peer Mentor

Long-term self-advocacy across MRI surveillance years. Advance care planning while capacity is clear. Caregiver wellness plan. Peer mentoring active. Story contributed to NMSS / FFH library. Earn Certified Prepared Patient · MS.

Learn It
My confidence (1–5)
Pre: — · Post: —
👥My Care Team

Your team is bigger than just the doctor — and the care partner is part of it. Click any card to edit, or click the + tile to add a new team member. Saved on this device. The Force Field Emergency Card below auto-syncs from this list. Starter roster pre-populated for Multiple Sclerosis — your institution can edit any row. The Force Field Emergency Card auto-syncs from this list.

Edit Team Member

📖Glossary — words you'll hear 10 plain-English terms · click any to expand

Plain-English definitions for terms doctors and labs use. Tap to expand.

Multiple sclerosis (MS)
An autoimmune disease in which the immune system attacks myelin — the insulation around nerve fibers — in the brain, spinal cord, and optic nerves. Three main types: relapsing-remitting (RRMS, ~85% at diagnosis), secondary progressive (SPMS), primary progressive (PPMS, ~10–15%). Modern high-efficacy DMT has changed the long-arc trajectory.
Demyelination
Loss of myelin around nerve fibers. The hallmark MS pathology. Damaged areas — called lesions or plaques — show up as bright spots on T2/FLAIR MRI sequences. Lesion location decides which symptom you get.
Relapse vs. pseudo-relapse
Relapse: new neurological symptom > 24 hours, > 30 days from previous attack, not explained by fever or exertion. Pseudo-relapse: old symptoms temporarily worse with heat (Uhthoff's), infection (UTI is #1), fatigue — settle when the trigger resolves. Real relapse → call your MS team within 24–48 hours.
Optic neuritis
Inflammation of the optic nerve. Classic presentation: painful vision loss in one eye, often with painful eye movement and color desaturation. One of the most common first attacks of MS. Same-day or next-day neurology / neuro-ophthalmology evaluation; brain + spine MRI; often IV steroids.
Lhermitte's sign
An electric-shock sensation running down the spine and into the limbs when the neck is flexed. Suggests a cervical-cord lesion. Common in MS; not unique to it.
Uhthoff's phenomenon
Temporary worsening of MS symptoms with elevated body temperature — heat, exercise, fever, hot showers. It is a pseudo-relapse, not a true relapse. Cooling vests, AC, cool showers, pre-cooling before exercise help. Not dangerous, just temporarily disabling.
EDSS (Expanded Disability Status Scale)
A 0–10 score of physical disability in MS, anchored mainly in walking and physical function. In plain language: 0 = normal exam, 4 = limited walking distance, 6 = needs aid for short walks, 7 = wheelchair-bound, 8 = bed-restricted, 10 = death. EDSS progression is the long-arc disability outcome DMTs are meant to prevent.
Notice and Name
The FFH Ambassador / family-observer practice. Write the change, the date, and a one-line example. Three notes accumulated over six weeks = a clinician conversation. Observation is always in scope; diagnosis is never in scope.
High-efficacy DMTs
Disease-modifying therapies with the strongest relapse-rate reduction and lesion suppression: ocrelizumab (Ocrevus), ofatumumab (Kesimpta), natalizumab (Tysabri), alemtuzumab (Lemtrada), cladribine (Mavenclad). Recent evidence (Lancet Neurology, AAN updates) supports starting high-efficacy early rather than escalating later.
Platform DMTs
The historical first-line MS drugs: interferon-betas, glatiramer acetate (Copaxone), dimethyl/diroximel fumarate (Tecfidera/Vumerity), teriflunomide (Aubagio). Lower efficacy than the high-efficacy agents; still appropriate for some patients.
Oral S1P modulators
Sphingosine-1-phosphate receptor modulators: fingolimod (Gilenya), ozanimod (Zeposia), siponimod (Mayzent), ponesimod (Ponvory). Daily oral pills with moderate-to-high efficacy. First-dose cardiac monitoring and ophthalmology screening required for some.
JCV antibody
Antibody against the JC virus, tested before and during natalizumab (Tysabri) therapy. JCV-positive patients with high antibody index carry an increased risk of progressive multifocal leukoencephalopathy (PML). The team monitors index and switches DMT if risk rises.
NEDA (No Evidence of Disease Activity)
The modern MS treatment goal: zero clinical relapses, zero new MRI T2 lesions, zero new gadolinium-enhancing lesions, no EDSS progression. NEDA is increasingly the standard against which DMT effectiveness is judged.
EBV (Epstein-Barr virus) and MS
A landmark 2022 Lancet study (Bjornevik et al.) of 10 million U.S. military personnel showed EBV infection precedes nearly all MS. EBV is now considered a near-prerequisite for MS — though clearly not sufficient on its own.
🧪Lab Test Tutor — what your numbers mean click to expand

Lab Test Tutor — what your numbers mean

Don't just see a number — know what it means and what to ask. Your "normal" may be different from a friend's. Ask your team to write your personal baseline in the column on the right.

TestWhat it measuresTypical adult rangeWhat to ask if it's offMy baseline
Brain + spine MRI (with/without gadolinium)The MS imaging workhorse. Counts T2/FLAIR lesions, identifies new gadolinium-enhancing lesions (active inflammation), tracks atrophy.Goal on stable DMT: zero new T2 + zero new gad-enhancing lesionsHow many new lesions since last scan? Any gadolinium-enhancing? My total T2 burden?[fill in]
EDSS (Expanded Disability Status Scale)Plain-language walking + physical-function score, 0–10. Tracked across years. EDSS progression is what DMTs aim to prevent.0 = normal exam · 4 = limited walking · 6 = aid for short walks · 8 = bed-restrictedWhat is my current EDSS? Any change since last visit?[fill in]
Annualized relapse rateNumber of relapses per year. The disease-activity outcome on DMT.Goal on DMT: <0.2 (ideally zero)How many relapses in the past 12 months?[fill in]
Vitamin D (25-OH)Low vitamin D is associated with higher relapse risk. Replenishment is cheap, evidence-supported.Target 40–60 ng/mLWhat is my level? Should I increase supplementation?[fill in]
JCV antibody index (if on / considering natalizumab)Tested before and during natalizumab (Tysabri). High index = increased PML risk; team adjusts DMT decisions accordingly.Index <0.9 lower-risk; index >1.5 higher-riskAm I JCV positive? What is my index? When is the next test?[fill in]
CBC + LFTs (DMT monitoring)Most DMTs require periodic CBC and liver function tests. Schedule depends on the agent (e.g., monthly for natalizumab, q3 mo for fingolimod, q3–6 mo for fumarates and teriflunomide).Drug-specific thresholds for actionAre my labs current? Any results that warrant a call?[fill in]
PHQ-9 / GAD-7 (mood screens)Depression and anxiety in MS exceed 50% lifetime — under-treated and treatable. Improvement helps fatigue, cognition, adherence.PHQ-9 ≥10 = moderate · GAD-7 ≥10 = moderateShould I be screened? If positive, what is the plan?[fill in]
Sleep study (PSG / home test)OSA is common in MS and worsens fatigue, cognition, and mood. STOP-BANG screen first.AHI ≥5 = OSA; treat with CPAPHave I been screened? Should I have a sleep study?[fill in]
BP / A1c / lipid panelVascular comorbidities accelerate MS disability. Same numbers as the upstream cluster.BP <130/80 · A1c <7% (if T2D) · LDL to ASCVD goalAm I at goal on the vascular numbers?[fill in]
DXA bone-density scanMultiple steroid pulses + reduced mobility raise osteoporosis risk in MS.T-score ≤ −2.5 = osteoporosis; −1 to −2.5 = osteopeniaShould I have a baseline DXA? Vitamin D + calcium adequate?[fill in]
Add-On Modules & Earnable Badges

Stackable modules that match your situation. Complete one to earn an extra badge on your certificate. Your institution can add their own.

Add-on
❄️ Cooling Vest — Daily Routine

Active vs evaporative options, when to pre-cool, summer-day plan, exercise prep, how to ask insurance to cover. Heat management is real medicine in MS.

Add-on
💉 Self-Injection Technique (Injectable DMT)

For glatiramer, interferon-beta, ofatumumab. Injection-site rotation, skin care, cold-storage logistics, missed-dose plan, side-effect tracking.

Add-on
🩺 Infusion-Day Routine (Infused DMT)

For ocrelizumab, natalizumab, alemtuzumab, rituximab. Pre-medication, hydration, what to bring, side-effect watch list, recovery day.

Add-on
🛁 Bladder Self-Cath Onboarding

For overactive bladder with retention. Sterile technique, supplies, UTI prevention (#1 trigger of pseudo-relapse), urology follow-up cadence.

Add-on
🏃 Home PT/OT Program

Aerobic + resistance + balance training adapted to your EDSS. Home exercise app integration, fall-prevention audit, energy-conservation pacing.

Add-on
📋 MRI Day Prep

Surveillance MRI checklist: gadolinium consent, kidney-function check, claustrophobia plan, results-conversation script, lesion-tracker update.

Trial
🧪 In a Clinical Trial?

Protocol literacy, side-effect tracking, when to call the study coordinator vs your usual MS team. ABTA TrialConnect / NMSS trial finder.

Add-on
📋 Advance Care Planning Workshop

POA, healthcare proxy, advance directive, POLST/MOLST, will, financial plan — done while capacity is clear (matters especially with progressive MS).

Family
👨‍👩‍👧 Care Partner Wellness

Care-partner PCP, mental-health, peer support, scheduled respite, back-up plan if the partner becomes unable to care. Real medicine.

Custom
+ Add Your Institution's Module

Drop in your own — local MS center onboarding, infusion-suite intro, peer-mentor program, anything.

🛡️Force Field Emergency Card Fridge · Wallet · EMT-ready

🛡️ Force Field Emergency Card FRIDGE · WALLET · EMT-READY

A one-page emergency record for any EMT, ER, new doctor, or transition visit. Print one for the fridge, one for your wallet. Updates anytime. This is the document you hand to a stranger when you can't speak for yourself.

🤝 My Care Team — call list for any clinician picking up my care
📘My Health Passport Patient-Owned Journal

📘 My Health Passport PATIENT-OWNED JOURNAL

This is your record — not your hospital's. Log every visit, capture every question for next time, and watch your own trends. Many of you get care at more than one hospital, on more than one record system. This Passport travels with you. Future versions will let you import data directly from your patient portals (the "Blue Button" vision).

        Blue Button vision: A future release will let you connect your patient portals (Epic MyChart, Cerner, Athena, VA, others) and pull your labs, meds, and visit history straight in. Until then, this Passport is your single, portable record across institutions — you own it.
        🩺Working With a Prepared Patient

        Your patient is going through a structured, evidence-based course. Here's how to get the most out of every visit, reduce ED use, support the care partner, and partner well. Built on the AHRQ SHARE Approach, the IOM teach-back method, AAN MS practice guidelines (DMT selection, monitoring, NEDA criteria), Lancet Neurology MS reviews, the McDonald 2017/2024 diagnostic criteria, and the National MS Society's clinical care framework.

        The SHARE Approach — your 5-step playbook

        Use these steps in any order. Cycle back. Use teach-back at every transition. Source: AHRQ Pub. No. 25-0005 (Oct 2024).

        💬Teach-Back & Risk Communication

        The two highest-yield, lowest-cost SDM techniques. Use both at every visit.

        🔁 Teach-Back (1–2 min)
        • "Just so I know I explained it well — what would you tell your partner about why we're recommending ocrelizumab (or staying on your current DMT)?"
        • Open-ended ("what" / "how"), not yes/no.
        • If they get it wrong: "I must not have explained it well — let me try a different way." Then teach-back again.
        • Use it for: relapse vs pseudo-relapse, the DMT plan + monitoring + side-effect call triggers, when to call vs ED, optic-neuritis recognition, advance care planning.
        • Document teach-back in your note — it's a quality measure and a billable element of care.
        🔢 Communicating Numbers
        • Use absolute risk, not relative. "13 out of 100" beats "13%" beats "1 in 8" beats "low risk."
        • Keep denominators & timeframes constant when comparing options.
        • Show, don't tell: icon arrays, Wong-Baker FACES, written summary.
        • For lab / score numbers: give the action threshold, not just the value. "Your EDSS went from 2 to 3 — under our DMT threshold we usually re-image and consider escalation."
        ⚠️MS-Specific Clinical Guardrails

        Diagnostic Workup

        • McDonald 2017/2024 criteria applied with brain + spine MRI; confirm dissemination in space and time.
        • Rule out look-alikes: NMOSD (AQP4-IgG), MOGAD (MOG-IgG), B12, vitamin D, TSH, HIV, syphilis, Lyme, CBC, CRP. Spinal lesions raise NMOSD index of suspicion.
        • Optic neuritis presentation: same-day ophthalmology + neuro-ophthalmology; brain + spine MRI; consider IV methylprednisolone.
        • JCV antibody baseline before any natalizumab consideration; recheck per protocol.
        • Vitamin D level; target 40–60 ng/mL; replenishment evidence-supported.

        Treatment

        • Start high-efficacy DMT early for active RRMS per current Lancet Neurology / AAN trajectory of evidence; counsel on PML, infection, and malignancy risk per agent.
        • Acute relapse: IV methylprednisolone 1 g/day × 3–5 days for moderate-to-severe relapses with functional impact; oral equivalent acceptable; rule out UTI / heat / fever first (pseudo-relapse is common).
        • Symptom management: modafinil/armodafinil for fatigue; baclofen/tizanidine for spasticity; oxybutynin/mirabegron/Botox for OAB; SSRIs/SNRIs for mood; dalfampridine for walking speed in selected patients.
        • Vascular comorbidities: HTN <130/80, A1c <7%, LDL to ASCVD-appropriate goal, treat OSA, smoking cessation — all accelerate MS disability if untreated.
        • Pregnancy planning: most DMTs need washout before conception; ocrelizumab and natalizumab have specific protocols; counsel patients early.
        • Bone health: DXA after multiple steroid pulses; vitamin D + calcium; consider bisphosphonates if indicated.
        🌍Cultural Competence & Trust

        MS disproportionately affects women (2–3× more often than men) and is diagnosed later and treated less aggressively in Black and Hispanic Americans, who also progress faster. Pediatric MS is under-recognized. Bias in diagnosis, DMT escalation, and clinical trial enrollment is well documented. Repair starts in your office.

        • Start with belief. When a young woman reports new numbness or vision change that "comes and goes," document, image, and refer. Early MS is often dismissed as anxiety, deconditioning, or "stress."
        • Ask about their model. "What do you and your family think is happening? What changes — vision, sensation, walking, fatigue — have you noticed over the last weeks to months?" Use that language.
        • Use qualified medical interpreters — never family, never minor children except in true emergencies. Neurological exam descriptions and DMT consent must be done in the patient's primary language.
        • Invite the care partner in. With patient consent — decisions about DMT selection, pregnancy planning, work accommodations, and long-arc planning are family decisions in many cultures.
        • Name the bias. "I know MS symptoms in young women and in Black and Hispanic patients are often dismissed or attributed to anxiety. We track that here, and you can tell me if it ever happens."
        🏥Customize for Your Institution

        Clone this course and replace the highlighted blocks with your own information. Each editable field below is a placeholder — change it once and it propagates through the patient view.

        📞 What Should Replace the When-to-Call Block
        • 24/7 MS clinic / neurology on-call number
        • MS clinic outpatient hours & address
        • MS specialty pharmacy line (DMT delivery + monitoring)
        • Behavioral health / care-partner support line
        • National MS Society local chapter contact
        • Patient portal login URL with care-partner proxy
        👤 Who Is Your MS Nurse Navigator?
        • Name, role, photo, calendly/booking link.
        • What teach-back / device check-ins they own (DMT adherence, cooling-vest use, pill dispenser, home BP cuff if vascular comorbid, CPAP if OSA).
        • How patients and care partners reach them between visits.
        • How they handle relapse triage and prior-auth navigation.
        📚 Add Your Own Modules
        • Your clinical trial protocols (high-efficacy DMT trials, remyelination trials, observational cohorts).
        • MS nurse navigator onboarding letter.
        • Insurance & financial-aid pathways (especially DMT copay assistance, foundation grants).
        • Local peer support partners (National MS Society local chapter, MSAA, caregiver support groups).
        🎨 Re-skin in 2 Lines of CSS
        • --inst-primary: your brand color
        • Replace the FFH × National MS Society × [Your Institution] cobrand in the hero
        • Drop in your logo PNG (white version) — same 48px height as FFH logo

        📚 Evidence Base — what this course is built on

        Course content is educational and not a substitute for medical advice from your own clinicians. Institutions cloning this course are responsible for accuracy of all customized blocks.

        Prepared Patient · Multiple SclerosisChapter 1 · Learn It

        1Module title

        Module description.

        Take the Pre-Check, work through Learn It → Live It → Share It, then take the Post-Check (≥4/5 to mark complete).